Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07644962
Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the Development of Prevention and Control StrategiesHuashan HospitalNot Yet Recruiting
NCT07644962Not Yet Recruiting
—
Research Project on the Interaction Between Immune Function and Infectious Disea...Huashan Hospital
NCT07644949
Self-Help Plus (SH+) for Stress Reduction in Social Service Workers: A Pilot RCTIstanbul Medeniyet UniversityNot Yet RecruitingNot Applicable
NCT07644949Not Yet Recruiting
Not Applicable
Self-Help Plus (SH+) for Stress Reduction in Social Service Workers: A Pilot RCTIstanbul Medeniyet Univer...
NCT07644325
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament BiopsyClinique Saint Jean, FranceRecruitingNot Applicable
NCT07644325Recruiting
Not Applicable
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior C...Clinique Saint Jean, Fran...
NCT07644494
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: The Impact of Spontaneous Respiratory EffortJingyuan,XuCompleted
NCT07644494Completed
—
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: Th...Jingyuan,Xu
NCT07646379
Effects of Spinal Mobilization With Leg Movement With and Without Neural Flossing Technique in Lumbar RadiculopathyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07646379Not Yet Recruiting
Not Applicable
Effects of Spinal Mobilization With Leg Movement With and Without Neural Flossin...Riphah International Univ...
NCT07645690
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell CarcinomaChinese PLA General HospitalRecruitingEarly Phase 1
NCT07645690Recruiting
Early Phase 1
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Meta...Chinese PLA General Hospi...
NCT07644481
Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete RemissionInstitute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingNot Applicable
NCT07644481Not Yet Recruiting
Not Applicable
Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melpha...Institute of Hematology &...
NCT07645235
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating WomenBiomedical Advanced Research and Development AuthorityNot Yet RecruitingPhase 1
NCT07645235Not Yet Recruiting
Phase 1
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Wom...Biomedical Advanced Resea...
NCT07646470
Effects of Chronic Non-invasive Vagus Nerve Stimulation in an Asplenic Individual Suffering From Rheumatoid ArthritisOsteoflow Health ClinicCompletedNot Applicable
NCT07646470Completed
Not Applicable
Effects of Chronic Non-invasive Vagus Nerve Stimulation in an Asplenic Individua...Osteoflow Health Clinic
NCT07646535
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary AldosteronismShenzhen Salubris Pharmaceuticals Co., Ltd.Not Yet RecruitingPhase 2
NCT07646535Not Yet Recruiting
Phase 2
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses i...Shenzhen Salubris Pharmac...
NCT07646067
Closed Loop Glucose Control in a Simulated ICU SettingEmory UniversityNot Yet RecruitingNot Applicable
NCT07646067Not Yet Recruiting
Not Applicable
Closed Loop Glucose Control in a Simulated ICU SettingEmory University
NCT07645560
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeBeijing Tiantan HospitalNot Yet RecruitingPhase 2
NCT07645560Not Yet Recruiting
Phase 2
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After...Beijing Tiantan Hospital
NCT07645612
A Just-in-Time Digital Learning Platform for Teacher Oral Health TrainingUniversiti Putra MalaysiaNot Yet RecruitingNot Applicable
NCT07645612Not Yet Recruiting
Not Applicable
A Just-in-Time Digital Learning Platform for Teacher Oral Health TrainingUniversiti Putra Malaysia
NCT07646223
Vancomycin Efficacy in Response to Dysbiosis in Atypical ColitisFimlab laboratoriesNot Yet RecruitingPhase 2
NCT07646223Not Yet Recruiting
Phase 2
Vancomycin Efficacy in Response to Dysbiosis in Atypical ColitisFimlab laboratories
NCT07644767
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty LtdNot Yet RecruitingPhase 2
NCT07644767Not Yet Recruiting
Phase 2
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty Lt...
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07646431
Comparative Effects Of Clamshell And Short Arc Quadriceps Exercises In Patellofemoral PainGreen International UniversityCompletedNot Applicable
NCT07646431Completed
Not Applicable
Comparative Effects Of Clamshell And Short Arc Quadriceps Exercises In Patellofe...Green International Unive...
NCT07646249
VENtilation Modalities During Transport of PostoperatIve CRITically Ill Patients to the ICUAzienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di AlessandriaNot Yet Recruiting
NCT07646249Not Yet Recruiting
—
VENtilation Modalities During Transport of PostoperatIve CRITically Ill Patients...Azienda Ospedaliera SS. A...
NCT07645326
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Georgetown UniversityNot Yet RecruitingPhase 2
NCT07645326Not Yet Recruiting
Phase 2
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Georgetown University
Result Breakdown
Not yet recruiting14 (70%)
Recruiting3 (15%)
Completed3 (15%)
not_applicable8 (40%)
Phase 26 (30%)
Not Specified3 (15%)
Phase 12 (10%)
Early Phase 11 (5%)